Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A randomized, open label, phase II study comparing pemetrexed plus cisplatin followed by pemetrexed versus pemetrexed alone in EGFR mutant NSCLC patients who have failed first-line EGFR TKI: KCSG-LU12-13.
- Authors
- Yoo, Kwai Han; Cho, Jinhyun; Lee, Ki Hyeong; Park, Keon Uk; Kim, Ki Hwan; Cho, Eun Kyung; Kwon, Kyung A.; Ahn, Heuijune; Kim, HyeRyun; Kim, Hoon-Gu; Lee, Ha Yeon; Yun, Hwan Jung; Kang, Jin-Hyoung; Jeong, Jaeheon; Choi, Moon Young; Jung, Sin-Ho; Sun, Jong -Mu; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju
- Issue Date
- 20-May-2016
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.34, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 34
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)